We are live on ! Find out more
MI

Motiv8 Investments Portfolio holdings

AUM $183K
1-Year Est. Return 15.06%
This Fund
S&P 500
This Quarter Est. Return
+2.41%
1 Year Est. Return
+15.06%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183K
AUM Growth
-$188M
Cap. Flow
-$27.3M
Cap. Flow %
-14,899.33%
Top 10 Hldgs %
34.37%
Holding
1,077
New
970
Increased
33
Reduced
56
Closed
12

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$1.55M
2
PLTR icon
Palantir
PLTR
+$1.43M
3
BKNG icon
Booking.com
BKNG
+$880K
4
FNOV icon
FT Vest US Equity Buffer ETF November
FNOV
+$414K
5
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$244K

Top Sells

Rank Stock Value
1
BND icon
Vanguard Total Bond Market
BND
+$6.63M
2
USIG icon
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
+$6.04M
3
SPTL icon
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
+$3.74M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.32M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$2.06M

Sector Composition

Rank Sector Weight
1 Technology 13.55%
2 Industrials 6.69%
3 Financials 5.17%
4 Healthcare 5.03%
5 Consumer Discretionary 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETHE
801
Grayscale Ethereum Staking ETF Shares
ETHE
$1.51B
$0 ﹤0.01%
+14
New +$398
GRCE
802
Grace Therapeutics
GRCE
$33.8M
$0 ﹤0.01%
+20
New +$64
DTCX
803
Datacentrex Inc
DTCX
$68.4M
$0 ﹤0.01%
+100
New +$425
RNTX
804
Rein Therapeutics
RNTX
$63.1M
$0 ﹤0.01%
+25
New +$34
VIRX
805
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$0 ﹤0.01%
+14
New –
AMLI
806
DELISTED
American Lithium Corp. Common Stock
AMLI
$0 ﹤0.01%
+500
New –
AVGR
807
DELISTED
Avinger, Inc. Common Stock
AVGR
$0 ﹤0.01%
+1
New –
AWH
808
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$0 ﹤0.01%
+33
New –
FUV
809
DELISTED
Arcimoto, Inc. Common Stock
FUV
$0 ﹤0.01%
+3
New –
MOTS
810
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$0 ﹤0.01%
+1
New –
DMK
811
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$0 ﹤0.01%
+14
New –
TBLT
812
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$0 ﹤0.01%
+1
New –
INFI
813
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$0 ﹤0.01%
+200
New –
KRBP
814
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$0 ﹤0.01%
+4
New –
HSTO
815
DELISTED
Histogen Inc. Common Stock
HSTO
$0 ﹤0.01%
+7
New –
ADXS
816
DELISTED
Advaxis Inc
ADXS
$0 ﹤0.01%
+17
New –
NBRV
817
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$0 ﹤0.01%
+6
New –
GNCA
818
DELISTED
Genocea Biosciences, Inc.
GNCA
$0 ﹤0.01%
+300
New –
NVIV
819
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$0 ﹤0.01%
+1
New –
VRUS
820
DELISTED
PHARMASSET, INC. COM
VRUS
$0 ﹤0.01%
+8
New –
STRD
821
DELISTED
STRATEGIC DISTRIBUTION INC-NEW
STRD
$0 ﹤0.01%
+1
New –
PDLI
822
DELISTED
PDL BioPharma, Inc.
PDLI
$0 ﹤0.01%
+875
New –
BBDA
823
DELISTED
BANK OF BERMUDA
BBDA
$0 ﹤0.01%
+750
New –
ARGS
824
DELISTED
Argos Therapeutics, Inc.
ARGS
$0 ﹤0.01%
+40
New –
BTTC
825
Black Titan Corp
BTTC
$7.4M
$0 ﹤0.01%
+4
New +$17
30 31 32
33
34

Similar funds

AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

Motiv8 Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Motiv8 Investments held 1,077 positions worth $183K, down 100% from $188M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Motiv8 Investments withdrew a net $27.3M in Q4 2025, closing 12 positions and reducing 56 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $6.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Motiv8 Investments opened a new position in Applovin worth $1.66K.

  • Motiv8 Investments's largest Q4 2025 buy was Applovin: 2,459 shares worth $1.66K.
  • Motiv8 Investments added most to Accenture in Q4 2025, an estimated $191K increase.
  • Motiv8 Investments's biggest Q4 2025 reduction was Innovator US Equity Power Buffer ETF October, cutting an estimated $1.84M.
  • Motiv8 Investments fully exited Vanguard Total Bond Market in Q4 2025, selling an estimated $6.63M.
  • Motiv8 Investments's ten largest holdings make up 34% of its $183K portfolio in Q4 2025.
  • Motiv8 Investments opened 970 new positions and closed 12 in Q4 2025.
  • Motiv8 Investments's portfolio value fell 100% quarter-over-quarter to $183K.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.